The highest ranked sMRI variables were the left caudate and right pars orbitalis, followed by the

right superior temporal cortex and right caudate, and then other PFC regions (Table 2). Top correlates of negative emotion Akt inhibitor performance included a frontostriatal cognitive-control network (bilateral caudate and putamen, bilateral rostral middle frontal, right caudal middle Inhibitors,research,lifescience,medical frontal, right BA pars opercularis, left pars triangularis), a memory retrieval hub (left precuneus), and visual processing regions (right lingual gyrus, bilateral lateral occipital cortex, left cuneus, and right middle-temporal cortex). The highest ranked sMRI variables were Inhibitors,research,lifescience,medical the right putamen and right lingual gyrus (Table 2). Top correlates of motor timing precision included a frontostriatal cognitive-control network (bilateral putamen, right caudate, left caudal middle

frontal, and right rostral middle frontal), sensorimotor cortex (left postcentral gyrus), and multimodal association centers (bilateral superior temporal and bilateral lateral occipital cortices). The highest ranked sMRI variable was the left caudal middle-frontal cortex, followed by bilateral putamen, right caudate, and bilateral superior temporal cortex (Table 2). Discussion This study demonstrated that functioning Inhibitors,research,lifescience,medical in different cognitive domains that are vulnerable to decline in prHD is associated with regionally specific patterns of both cortical and striatal morphometry. Inhibitors,research,lifescience,medical Although caudate and/or putamen volumes in prHD are known to correlate with cognitive performances on several tests (e.g., SDMT, Stroop Interference, Verbal Fluency, WCST, Trail Making Test) (Campodonico et al. 1998; Jurgens et al. 2008; Paulsen et al. 2010; Wolf et al. 2013), most studies report no relationship between cortical Inhibitors,research,lifescience,medical volume loss or thinning and cognition (Novak et al. 2012; Wolf et al. 2013), with one notable exception (Rosas et al. 2005). This is surprising given the widespread oxyclozanide changes

in cortical morphometry in prHD (Nopoulos et al. 2010). Discrepant findings may relate to variations among studies in imaging processing methods, sample size, and levels of proximity to disease onset. Individuals far from diagnosis (more than 15 years) typically perform similarly to controls on most cognitive measures, whereas those closer to diagnosis perform more poorly relative to gene-negative controls (Stout et al. 2011). Likewise, striatal volumes decrease and cortical thinning increases with proximity to diagnosis (Nopoulos et al. 2010; Paulsen et al. 2010). However, individuals far from diagnosis do not exhibit significant cortical thinning (Nopoulos et al. 2010), although striatal volumes can be reduced.